VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
Science Advances · 2023
DOI: 10.1126/sciadv.adg2339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Zhiqiang Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Virus Diseases, Interferon Type I. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys 372 by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Joint Surgery, the Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
- Department of Cell Biology, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China.
- Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
- Yue Bei People's Hospital Postdoctoral Innovation Practice Base, Southern Medical University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Lab of Single Cell Technology and Application, Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Zhiqiang Hu, Yingchao Xie, Jiahuan Zhang, Huaji Jiang, Yufeng Zhang, Dan Wu, Xiaochun Bai, Xiao Yu
Zitieren
APA
Hu, Z., Xie, Y., Lu, J., Yang, J., Zhang, J., Jiang, H., Li, H., Zhang, Y., Wu, D., Zeng, K., Bai, X., & Yu, X. (2023). VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. Science Advances. https://doi.org/10.1126/sciadv.adg2339
Vancouver
Hu Z, Xie Y, Lu J, Yang J, Zhang J, Jiang H, et al. VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. Science Advances. 2023. doi:10.1126/sciadv.adg2339
BibTeX
@article{Hu2023,
author = {Hu, Zhiqiang and Xie, Yingchao and Lu, Jiansen and Yang, Jianwu and Zhang, Jiahuan and Jiang, Huaji and Li, Hongyu and Zhang, Yufeng and Wu, Dan and Zeng, Ke and Bai, Xiaochun and Yu, Xiao},
title = {VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adg2339}
}
EUVIMED